Studies on pancreatic carcinoma, gastrointestinal cancers, colorectal carcinoma and miscellaneous tumors suggest that it is convenient to detect circulating tumor cells based on KRT20 RT-PCR assays (Joosse et al., 2012; Lukyanchuk et al., 2003). This evidence concerns the gene KRT20 and colorectal carcinoma.